Table 1.

Lung metastasis in the LM8‐inoculated mice

Treatment group	Mice with metastasis	Total mice examined	Incidence (%)
IFNγ (IT) +DC	4	7	57
IFNγ (IV) +DC	5	7	71
IFNγ (IT)	7	7	100
IFNγ (IV)	6	7	86
Cont (IT) +DC	5	7	71
Cont (IV) +DC	5	7	71
Untreated	6	7	86
CD40L (IT) +DC	5	8	63
CD40L (IV) +DC	4	8	50
CD40L (IT)	6	8	75
CD40L (IV)	6	8	75
Cont (IT) +DC	5	8	63
Cont (IV) +DC	5	8	63
Untreated	7	8	88
Comb (IT) +DC	0	6	0†
Comb (IV) +DC	0	6	0‡
Comb (IT)	3	6	50
Comb (IV)	2	6	33
Cont (IT) +DC	4	6	67
Cont (IV) +DC	4	6	67
Untreated	6	6	100

^† P < .01 vs “Utreated” group and P < .05 vs “Cont (IT) +DC” group by χ ² test.

^‡ P < .01 vs “Utreated” group and P < .05 vs “Cont (IV) +DC” group by χ ² test.